Status:
COMPLETED
Registry of Acute Stroke Under New Oral Anticoagulants -Pilot (RASUNOA-Pilot)
Lead Sponsor:
University Hospital Heidelberg
Conditions:
Ischemic Stroke
Intracranial Hemorrhage
Eligibility:
All Genders
18+ years
Brief Summary
The registry of acute stroke under new oral anticoagulants (RASUNOA) is a German multicenter, prospective, observational registry performed at about 50 study centers covering about 50.000 acute ischem...
Detailed Description
The main purpose of the study is to collect information from a large, prospectively enrolling multicentre stroke database regarding the optimal management of ischemic and hemorrhagic stroke during ant...
Eligibility Criteria
Inclusion
- age \>= 18 years
- informed consent
- acute stroke or intracranial bleeding
- therapy with a new oral anticoagulant (Dabigatran®, Rivaroxaban®, Apixaban®, Edoxaban®)
Exclusion
- missing informed consent
Key Trial Info
Start Date :
January 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2015
Estimated Enrollment :
353 Patients enrolled
Trial Details
Trial ID
NCT01850797
Start Date
January 1 2012
End Date
August 1 2015
Last Update
August 18 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Heidelberg
Heidelberg, Germany, 69120